Effect of a Multispecies Synbiotic Supplementation on Body Composition, Antioxidant Status, and Gut Microbiomes in Overweight and Obese Subjects: A Randomized, Double-Blind, Placebo-Controlled Study

Studies investigating the effect of multispecies synbiotic supplementation in obesity management are limited. The current study was performed to evaluate the effects of multispecies probiotics mixed with fructooligosaccharides on body composition, antioxidant status, and gut microbiome composition i...

Full description

Saved in:
Bibliographic Details
Published inNutrients Vol. 15; no. 8; p. 1863
Main Authors Oraphruek, Piyarat, Chusak, Charoonsri, Ngamukote, Sathaporn, Sawaswong, Vorthon, Chanchaem, Prangwalai, Payungporn, Sunchai, Suantawee, Tanyawan, Adisakwattana, Sirichai
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 13.04.2023
MDPI
Subjects
antioxidant activity
Antioxidants
Antioxidants - pharmacology
Bacteroidetes
blood
Body Composition
Body fat
Body mass index
Cytokines
Diet therapy
Dietary supplements
digestive system
Double-Blind Method
Double-blind studies
Firmicutes
fructooligosaccharides
Gastrointestinal Microbiome
Gastrointestinal system
Health aspects
Humans
Inflammation
intestinal microorganisms
malondialdehyde
maltodextrins
Metabolism
microbiome
Microbiota
Microbiota (Symbiotic organisms)
Obesity
Obesity - therapy
Overweight
Overweight - therapy
Oxidative stress
Physiological aspects
placebos
Plasma
Prebiotics
Probiotics
Synbiotics
Tumor necrosis factor-TNF
waist circumference
Weight control
Thailand
St Louis Missouri
United States > US
Germany
Bangkok Thailand
probiotic
prebiotic
gut microbiota
synbiotic
overweight and obesity
Online AccessGet full text

Cover

Abstract Studies investigating the effect of multispecies synbiotic supplementation in obesity management are limited. The current study was performed to evaluate the effects of multispecies probiotics mixed with fructooligosaccharides on body composition, antioxidant status, and gut microbiome composition in overweight and obese individuals. We employed a randomized, double-blind, placebo-controlled trial design, in which 63 individuals aged 18–45 years were assigned to receive either a synbiotic supplement or placebo for 12 weeks. The synbiotic group consumed a daily dose of 37 × 109 colony-forming units (CFU) of a unique blend of seven different probiotics, along with 2 g of fructooligosaccharides, while the placebo group consumed 2 g of maltodextrin daily. Assessments were performed at baseline, week 6, and the end of the study. The results of the study indicated that synbiotic supplementation resulted in a significant reduction in waist circumference and body fat percentage compared to the baseline measurements, as observed at 12 weeks. At the end of the study, there were no significant differences observed in body weight, BMI, waist circumference, or percentage of body fat between the synbiotic group and the placebo group. An analysis of plasma antioxidant capacity revealed that synbiotic supplementation caused a significant increase in Trolox equivalent antioxidant capacity (TEAC) and a concomitant decrease in malondialdehyde (MDA) in the test group when compared to the placebo. For the gut microbiota analysis, synbiotic supplementation significantly decreased Firmicutes abundance and the Firmicutes/Bacteroidetes (F/B) ratio at week 12 as compared to the placebo group. Nevertheless, the synbiotic group did not exhibit any substantial alterations in other biochemical blood parameters compared to the placebo group. These findings suggest that multispecies synbiotic supplementation could be a beneficial strategy to improve body composition, antioxidant status, and gut microbiome composition in overweight and obese subjects.
AbstractList Studies investigating the effect of multispecies synbiotic supplementation in obesity management are limited. The current study was performed to evaluate the effects of multispecies probiotics mixed with fructooligosaccharides on body composition, antioxidant status, and gut microbiome composition in overweight and obese individuals. We employed a randomized, double-blind, placebo-controlled trial design, in which 63 individuals aged 18-45 years were assigned to receive either a synbiotic supplement or placebo for 12 weeks. The synbiotic group consumed a daily dose of 37 × 10[sup.9] colony-forming units (CFU) of a unique blend of seven different probiotics, along with 2 g of fructooligosaccharides, while the placebo group consumed 2 g of maltodextrin daily. Assessments were performed at baseline, week 6, and the end of the study. The results of the study indicated that synbiotic supplementation resulted in a significant reduction in waist circumference and body fat percentage compared to the baseline measurements, as observed at 12 weeks. At the end of the study, there were no significant differences observed in body weight, BMI, waist circumference, or percentage of body fat between the synbiotic group and the placebo group. An analysis of plasma antioxidant capacity revealed that synbiotic supplementation caused a significant increase in Trolox equivalent antioxidant capacity (TEAC) and a concomitant decrease in malondialdehyde (MDA) in the test group when compared to the placebo. For the gut microbiota analysis, synbiotic supplementation significantly decreased Firmicutes abundance and the Firmicutes/Bacteroidetes (F/B) ratio at week 12 as compared to the placebo group. Nevertheless, the synbiotic group did not exhibit any substantial alterations in other biochemical blood parameters compared to the placebo group. These findings suggest that multispecies synbiotic supplementation could be a beneficial strategy to improve body composition, antioxidant status, and gut microbiome composition in overweight and obese subjects.
Studies investigating the effect of multispecies synbiotic supplementation in obesity management are limited. The current study was performed to evaluate the effects of multispecies probiotics mixed with fructooligosaccharides on body composition, antioxidant status, and gut microbiome composition in overweight and obese individuals. We employed a randomized, double-blind, placebo-controlled trial design, in which 63 individuals aged 18–45 years were assigned to receive either a synbiotic supplement or placebo for 12 weeks. The synbiotic group consumed a daily dose of 37 × 109 colony-forming units (CFU) of a unique blend of seven different probiotics, along with 2 g of fructooligosaccharides, while the placebo group consumed 2 g of maltodextrin daily. Assessments were performed at baseline, week 6, and the end of the study. The results of the study indicated that synbiotic supplementation resulted in a significant reduction in waist circumference and body fat percentage compared to the baseline measurements, as observed at 12 weeks. At the end of the study, there were no significant differences observed in body weight, BMI, waist circumference, or percentage of body fat between the synbiotic group and the placebo group. An analysis of plasma antioxidant capacity revealed that synbiotic supplementation caused a significant increase in Trolox equivalent antioxidant capacity (TEAC) and a concomitant decrease in malondialdehyde (MDA) in the test group when compared to the placebo. For the gut microbiota analysis, synbiotic supplementation significantly decreased Firmicutes abundance and the Firmicutes/Bacteroidetes (F/B) ratio at week 12 as compared to the placebo group. Nevertheless, the synbiotic group did not exhibit any substantial alterations in other biochemical blood parameters compared to the placebo group. These findings suggest that multispecies synbiotic supplementation could be a beneficial strategy to improve body composition, antioxidant status, and gut microbiome composition in overweight and obese subjects.
Studies investigating the effect of multispecies synbiotic supplementation in obesity management are limited. The current study was performed to evaluate the effects of multispecies probiotics mixed with fructooligosaccharides on body composition, antioxidant status, and gut microbiome composition in overweight and obese individuals. We employed a randomized, double-blind, placebo-controlled trial design, in which 63 individuals aged 18–45 years were assigned to receive either a synbiotic supplement or placebo for 12 weeks. The synbiotic group consumed a daily dose of 37 × 10 9 colony-forming units (CFU) of a unique blend of seven different probiotics, along with 2 g of fructooligosaccharides, while the placebo group consumed 2 g of maltodextrin daily. Assessments were performed at baseline, week 6, and the end of the study. The results of the study indicated that synbiotic supplementation resulted in a significant reduction in waist circumference and body fat percentage compared to the baseline measurements, as observed at 12 weeks. At the end of the study, there were no significant differences observed in body weight, BMI, waist circumference, or percentage of body fat between the synbiotic group and the placebo group. An analysis of plasma antioxidant capacity revealed that synbiotic supplementation caused a significant increase in Trolox equivalent antioxidant capacity (TEAC) and a concomitant decrease in malondialdehyde (MDA) in the test group when compared to the placebo. For the gut microbiota analysis, synbiotic supplementation significantly decreased Firmicutes abundance and the Firmicutes / Bacteroidetes (F/B) ratio at week 12 as compared to the placebo group. Nevertheless, the synbiotic group did not exhibit any substantial alterations in other biochemical blood parameters compared to the placebo group. These findings suggest that multispecies synbiotic supplementation could be a beneficial strategy to improve body composition, antioxidant status, and gut microbiome composition in overweight and obese subjects.
Studies investigating the effect of multispecies synbiotic supplementation in obesity management are limited. The current study was performed to evaluate the effects of multispecies probiotics mixed with fructooligosaccharides on body composition, antioxidant status, and gut microbiome composition in overweight and obese individuals. We employed a randomized, double-blind, placebo-controlled trial design, in which 63 individuals aged 18-45 years were assigned to receive either a synbiotic supplement or placebo for 12 weeks. The synbiotic group consumed a daily dose of 37 × 10 colony-forming units (CFU) of a unique blend of seven different probiotics, along with 2 g of fructooligosaccharides, while the placebo group consumed 2 g of maltodextrin daily. Assessments were performed at baseline, week 6, and the end of the study. The results of the study indicated that synbiotic supplementation resulted in a significant reduction in waist circumference and body fat percentage compared to the baseline measurements, as observed at 12 weeks. At the end of the study, there were no significant differences observed in body weight, BMI, waist circumference, or percentage of body fat between the synbiotic group and the placebo group. An analysis of plasma antioxidant capacity revealed that synbiotic supplementation caused a significant increase in Trolox equivalent antioxidant capacity (TEAC) and a concomitant decrease in malondialdehyde (MDA) in the test group when compared to the placebo. For the gut microbiota analysis, synbiotic supplementation significantly decreased abundance and the / (F/B) ratio at week 12 as compared to the placebo group. Nevertheless, the synbiotic group did not exhibit any substantial alterations in other biochemical blood parameters compared to the placebo group. These findings suggest that multispecies synbiotic supplementation could be a beneficial strategy to improve body composition, antioxidant status, and gut microbiome composition in overweight and obese subjects.
Studies investigating the effect of multispecies synbiotic supplementation in obesity management are limited. The current study was performed to evaluate the effects of multispecies probiotics mixed with fructooligosaccharides on body composition, antioxidant status, and gut microbiome composition in overweight and obese individuals. We employed a randomized, double-blind, placebo-controlled trial design, in which 63 individuals aged 18–45 years were assigned to receive either a synbiotic supplement or placebo for 12 weeks. The synbiotic group consumed a daily dose of 37 × 10⁹ colony-forming units (CFU) of a unique blend of seven different probiotics, along with 2 g of fructooligosaccharides, while the placebo group consumed 2 g of maltodextrin daily. Assessments were performed at baseline, week 6, and the end of the study. The results of the study indicated that synbiotic supplementation resulted in a significant reduction in waist circumference and body fat percentage compared to the baseline measurements, as observed at 12 weeks. At the end of the study, there were no significant differences observed in body weight, BMI, waist circumference, or percentage of body fat between the synbiotic group and the placebo group. An analysis of plasma antioxidant capacity revealed that synbiotic supplementation caused a significant increase in Trolox equivalent antioxidant capacity (TEAC) and a concomitant decrease in malondialdehyde (MDA) in the test group when compared to the placebo. For the gut microbiota analysis, synbiotic supplementation significantly decreased Firmicutes abundance and the Firmicutes/Bacteroidetes (F/B) ratio at week 12 as compared to the placebo group. Nevertheless, the synbiotic group did not exhibit any substantial alterations in other biochemical blood parameters compared to the placebo group. These findings suggest that multispecies synbiotic supplementation could be a beneficial strategy to improve body composition, antioxidant status, and gut microbiome composition in overweight and obese subjects.
Studies investigating the effect of multispecies synbiotic supplementation in obesity management are limited. The current study was performed to evaluate the effects of multispecies probiotics mixed with fructooligosaccharides on body composition, antioxidant status, and gut microbiome composition in overweight and obese individuals. We employed a randomized, double-blind, placebo-controlled trial design, in which 63 individuals aged 18-45 years were assigned to receive either a synbiotic supplement or placebo for 12 weeks. The synbiotic group consumed a daily dose of 37 × 109 colony-forming units (CFU) of a unique blend of seven different probiotics, along with 2 g of fructooligosaccharides, while the placebo group consumed 2 g of maltodextrin daily. Assessments were performed at baseline, week 6, and the end of the study. The results of the study indicated that synbiotic supplementation resulted in a significant reduction in waist circumference and body fat percentage compared to the baseline measurements, as observed at 12 weeks. At the end of the study, there were no significant differences observed in body weight, BMI, waist circumference, or percentage of body fat between the synbiotic group and the placebo group. An analysis of plasma antioxidant capacity revealed that synbiotic supplementation caused a significant increase in Trolox equivalent antioxidant capacity (TEAC) and a concomitant decrease in malondialdehyde (MDA) in the test group when compared to the placebo. For the gut microbiota analysis, synbiotic supplementation significantly decreased Firmicutes abundance and the Firmicutes/Bacteroidetes (F/B) ratio at week 12 as compared to the placebo group. Nevertheless, the synbiotic group did not exhibit any substantial alterations in other biochemical blood parameters compared to the placebo group. These findings suggest that multispecies synbiotic supplementation could be a beneficial strategy to improve body composition, antioxidant status, and gut microbiome composition in overweight and obese subjects.Studies investigating the effect of multispecies synbiotic supplementation in obesity management are limited. The current study was performed to evaluate the effects of multispecies probiotics mixed with fructooligosaccharides on body composition, antioxidant status, and gut microbiome composition in overweight and obese individuals. We employed a randomized, double-blind, placebo-controlled trial design, in which 63 individuals aged 18-45 years were assigned to receive either a synbiotic supplement or placebo for 12 weeks. The synbiotic group consumed a daily dose of 37 × 109 colony-forming units (CFU) of a unique blend of seven different probiotics, along with 2 g of fructooligosaccharides, while the placebo group consumed 2 g of maltodextrin daily. Assessments were performed at baseline, week 6, and the end of the study. The results of the study indicated that synbiotic supplementation resulted in a significant reduction in waist circumference and body fat percentage compared to the baseline measurements, as observed at 12 weeks. At the end of the study, there were no significant differences observed in body weight, BMI, waist circumference, or percentage of body fat between the synbiotic group and the placebo group. An analysis of plasma antioxidant capacity revealed that synbiotic supplementation caused a significant increase in Trolox equivalent antioxidant capacity (TEAC) and a concomitant decrease in malondialdehyde (MDA) in the test group when compared to the placebo. For the gut microbiota analysis, synbiotic supplementation significantly decreased Firmicutes abundance and the Firmicutes/Bacteroidetes (F/B) ratio at week 12 as compared to the placebo group. Nevertheless, the synbiotic group did not exhibit any substantial alterations in other biochemical blood parameters compared to the placebo group. These findings suggest that multispecies synbiotic supplementation could be a beneficial strategy to improve body composition, antioxidant status, and gut microbiome composition in overweight and obese subjects.
Audience Academic
Author Suantawee, Tanyawan
Adisakwattana, Sirichai
Chanchaem, Prangwalai
Ngamukote, Sathaporn
Payungporn, Sunchai
Chusak, Charoonsri
Oraphruek, Piyarat
Sawaswong, Vorthon
AuthorAffiliation 3 Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
1 Phytochemical and Functional Food Research Unit for Clinical Nutrition, Department of Nutrition and Dietetics, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand
2 Center of Excellence in Systems Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
AuthorAffiliation_xml – name: 2 Center of Excellence in Systems Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
– name: 1 Phytochemical and Functional Food Research Unit for Clinical Nutrition, Department of Nutrition and Dietetics, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand
– name: 3 Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
Author_xml – sequence: 1
  givenname: Piyarat
  surname: Oraphruek
  fullname: Oraphruek, Piyarat
– sequence: 2
  givenname: Charoonsri
  surname: Chusak
  fullname: Chusak, Charoonsri
– sequence: 3
  givenname: Sathaporn
  surname: Ngamukote
  fullname: Ngamukote, Sathaporn
– sequence: 4
  givenname: Vorthon
  surname: Sawaswong
  fullname: Sawaswong, Vorthon
– sequence: 5
  givenname: Prangwalai
  surname: Chanchaem
  fullname: Chanchaem, Prangwalai
– sequence: 6
  givenname: Sunchai
  surname: Payungporn
  fullname: Payungporn, Sunchai
– sequence: 7
  givenname: Tanyawan
  orcidid: 0000-0001-5691-0511
  surname: Suantawee
  fullname: Suantawee, Tanyawan
– sequence: 8
  givenname: Sirichai
  orcidid: 0000-0002-7938-6561
  surname: Adisakwattana
  fullname: Adisakwattana, Sirichai
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37111082$$D View this record in MEDLINE/PubMed
BookMark eNqFkt1u1DAQhSNUREvpDQ-ALHGD0KbYcRIn3KDtUgpSq0UsXEeOM966cuwQJ4XlAXkuJmxLf1SJOJKTyTdnrJPzNNpx3kEUPWf0kPOSvnEjy2jBipw_ivYSKpI4z1O-c-t5NzoI4YJOl6Ai50-iXS4YY7RI9qLfx1qDGojXRJKz0Q4mdKAMBLLauNr4wSiyGrvOQgtukIPxjuB95JsNWfi288FMtRmZO9x_mka6gawQHMOMSNeQk3EgZ0b1HsValDWOLC-h_wFmfT78JZY1BMAh9QUeJLwlc_IFy741v6CZkfd-rC3ER9Y4fPtspYLaxwvvht5bCw0OG5vNs-ixljbAwdW-H337cPx18TE-XZ58WsxPY5UJPsRlmjeJFqBB6Exkpc64lJxzmvFMCakLXtR1w3PIoS7LnEnVsEIzTnFoU5Sc70fvtrrdWLfQKPSkl7bqetPKflN5aaq7X5w5r9b-smKUpYxmCSq8ulLo_fcRwlC1JiiwVjrwY6g4TafFWfFfNCmoKPE3i0n15T30wo-9QysmKs9Klor0hlpLC5Vx2uMZ1SRazQUCuUhEidThAxSuBlqjMH3aYP1Ow4vbpvxz4zplCNAtgDEIoQddKbPNEiobi-ZUU5armyxjy-t7LdeqD8B_ACWW9To
CitedBy_id crossref_primary_10_3390_bioengineering11060574
crossref_primary_10_1016_j_ejim_2023_10_002
crossref_primary_10_1186_s13098_024_01561_z
crossref_primary_10_1292_jvms_24_0148
crossref_primary_10_1016_j_tifs_2025_104876
crossref_primary_10_1007_s11274_024_04085_w
crossref_primary_10_1016_j_phanu_2024_100402
crossref_primary_10_3390_antiox13111386
crossref_primary_10_1111_obr_13667
crossref_primary_10_1039_D4FO00711E
crossref_primary_10_1016_j_fochx_2024_102041
crossref_primary_10_1111_ijfs_16941
crossref_primary_10_1080_09637486_2024_2437472
crossref_primary_10_1007_s00404_024_07833_3
crossref_primary_10_1017_S1368980024002003
Cites_doi 10.1038/nature07540
10.1016/j.ctim.2019.102216
10.1373/clinchem.2004.031526
10.1016/j.jsbmb.2020.105737
10.1007/s11745-013-3867-2
10.1093/ajcn/47.5.789
10.1016/j.clnu.2016.10.003
10.1002/oby.21671
10.1126/science.1110591
10.1128/AEM.71.12.8228-8235.2005
10.1089/jmf.2017.3937
10.1097/NT.0000000000000167
10.1038/s41596-019-0264-1
10.1016/j.gtc.2005.05.002
10.3390/nu12010222
10.1586/17474124.2015.1051029
10.1016/j.phrs.2018.11.011
10.1142/S0192415X14500219
10.1093/bioinformatics/btaa900
10.1080/10408398.2018.1545218
10.1038/srep00799
10.1016/j.clnesp.2019.02.003
10.3390/nu13020666
10.3920/BM2018.0028
10.1016/j.ijfoodmicro.2004.05.012
10.3920/BM2019.0052
10.1038/s41430-020-0607-6
10.3390/foods10071580
10.1177/15353702221118091
10.7717/peerj.9230
10.1039/D1FO04428A
10.1002/oby.21654
10.1186/s13059-019-1727-y
10.3746/pnf.2021.26.1.40
10.1017/S0007114520000380
10.1007/s12602-018-9499-3
10.1186/s13104-020-05408-4
10.1093/nar/gkg039
10.3920/BM2015.0011
10.1038/s41598-022-21056-z
10.2337/db10-0253
10.1038/nature05414
10.3390/microorganisms8111715
10.1038/s41522-019-0091-8
10.29252/ibj.24.3.148
10.1089/met.2015.0095
10.3889/oamjms.2021.7625
10.3390/nu11112690
10.3390/ijms12053117
10.1186/s12889-021-10403-w
10.1016/j.cofs.2021.02.014
10.1038/ijo.2017.281
10.1007/s004250050524
10.1002/oby.20993
10.1016/0003-9861(59)90090-6
10.1073/pnas.0504978102
10.12938/bmfh.18-001
10.3390/ijerph17207618
10.1038/ajgsup.2012.5
10.1080/19390211.2018.1455788
10.1186/s41043-018-0158-9
ContentType Journal Article
Copyright COPYRIGHT 2023 MDPI AG
2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2023 by the authors. 2023
Copyright_xml – notice: COPYRIGHT 2023 MDPI AG
– notice: 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2023 by the authors. 2023
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TS
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
7S9
L.6
5PM
DOI 10.3390/nu15081863
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Physical Education Index
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
Coronavirus Research Database
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
Physical Education Index
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList
Publicly Available Content Database

MEDLINE
CrossRef
AGRICOLA
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 2072-6643
ExternalDocumentID PMC10141052
A747467279
37111082
10_3390_nu15081863
Genre Randomized Controlled Trial
Journal Article
GeographicLocations Thailand
St Louis Missouri
United States--US
Germany
Bangkok Thailand
GeographicLocations_xml – name: Thailand
– name: Bangkok Thailand
– name: Germany
– name: St Louis Missouri
– name: United States--US
GrantInformation_xml – fundername: Innovation and technology assistance program (ITAP), National Science and Technology Development Agency (NSTDA) and Absolute Well Being Group Co.,Ltd
  grantid: ITAP
– fundername: National Research Council of Thailand
  grantid: N42A640325
– fundername: National Science and Technology Development Agency (NSTDA)
– fundername: Innovation and technology assistance program (ITAP)
– fundername: Absolute Well Being Group Co., Ltd
– fundername: National Research Council of Thailand (NRCT)
  grantid: N42A640325
GroupedDBID ---
53G
5VS
7X7
88E
8FE
8FH
8FI
8FJ
A8Z
AADQD
AAFWJ
AAHBH
AAWTL
AAYXX
ABUWG
ACIWK
ACPRK
AENEX
AFKRA
AFRAH
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
APEBS
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
DIK
E3Z
EBD
ECGQY
EIHBH
ESTFP
EYRJQ
F5P
FYUFA
GX1
HMCUK
HYE
IAO
ITC
KQ8
LK8
M1P
M48
MODMG
M~E
OK1
OZF
P2P
P6G
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RPM
TR2
UKHRP
3V.
ATCPS
BBNVY
BHPHI
CGR
CUY
CVF
ECM
EIF
GROUPED_DOAJ
HCIFZ
M0K
M7P
NPM
PMFND
7TS
7XB
8FK
AZQEC
COVID
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
7S9
L.6
5PM
ID FETCH-LOGICAL-c573t-946d2f7efe7f5759f53aa3330535c7af838bbd36e6eb9961acd18f130cebd8933
IEDL.DBID M48
ISSN 2072-6643
IngestDate Thu Aug 21 18:37:39 EDT 2025
Wed Jul 30 10:58:00 EDT 2025
Fri Jul 11 04:10:48 EDT 2025
Sat Aug 23 12:40:01 EDT 2025
Tue Jun 17 20:59:51 EDT 2025
Tue Jun 10 20:42:25 EDT 2025
Thu Jan 02 22:53:15 EST 2025
Thu Apr 24 22:57:52 EDT 2025
Tue Jul 01 02:16:07 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords probiotic
prebiotic
gut microbiota
synbiotic
overweight and obesity
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c573t-946d2f7efe7f5759f53aa3330535c7af838bbd36e6eb9961acd18f130cebd8933
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ORCID 0000-0001-5691-0511
0000-0002-7938-6561
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/nu15081863
PMID 37111082
PQID 2806591474
PQPubID 2032353
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10141052
proquest_miscellaneous_3040404318
proquest_miscellaneous_2807920772
proquest_journals_2806591474
gale_infotracmisc_A747467279
gale_infotracacademiconefile_A747467279
pubmed_primary_37111082
crossref_citationtrail_10_3390_nu15081863
crossref_primary_10_3390_nu15081863
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20230413
PublicationDateYYYYMMDD 2023-04-13
PublicationDate_xml – month: 4
  year: 2023
  text: 20230413
  day: 13
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Nutrients
PublicationTitleAlternate Nutrients
PublicationYear 2023
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Hibberd (ref_13) 2019; 10
ref_50
Chusak (ref_17) 2014; 42
Suriyaprom (ref_5) 2019; 38
ref_14
Rabiei (ref_37) 2015; 29
Mathur (ref_42) 2015; 9
Soleimani (ref_60) 2019; 11
Pekkala (ref_54) 2015; 23
Carmona (ref_45) 2018; 42
Furet (ref_8) 2010; 59
Herisson (ref_10) 2021; 41
Lozupone (ref_47) 2005; 71
Manna (ref_57) 2015; 13
Ley (ref_7) 2005; 102
ref_61
Bengmark (ref_30) 2005; 34
ref_23
Dhawan (ref_36) 2020; 203
Rabiei (ref_11) 2019; 16
ref_64
Roshan (ref_62) 2019; 30
Gomes (ref_15) 2017; 25
Ipar (ref_35) 2015; 6
Minami (ref_38) 2018; 37
Jeong (ref_27) 2021; 26
Amabebe (ref_29) 2020; 123
Ferrarese (ref_65) 2018; 22
Hassan (ref_55) 2021; 9
Cole (ref_25) 2003; 31
Davis (ref_28) 2016; 51
DiBaise (ref_40) 2012; 1
Chong (ref_26) 2020; 15
Hadi (ref_33) 2019; 47
Ellman (ref_19) 1959; 82
Hodges (ref_20) 1999; 207
Finotello (ref_43) 2018; 19
Adenan (ref_6) 2020; 8
Timmerman (ref_31) 2004; 96
Kim (ref_39) 2018; 21
Stanislawski (ref_46) 2019; 5
Marvasti (ref_52) 2020; 24
Kawasaki (ref_4) 2012; 2
Ciuffreda (ref_24) 2021; 37
Turnbaugh (ref_44) 2006; 444
Taghizadeh (ref_63) 2014; 49
Wang (ref_18) 2004; 50
Bautista (ref_59) 2011; 12
Hassan (ref_53) 2022; 12
Fernandes (ref_12) 2017; 36
McCutcheon (ref_16) 1988; 47
Sudha (ref_34) 2019; 10
McMurray (ref_56) 2016; 24
Sepidarkish (ref_58) 2019; 139
Crovesy (ref_51) 2020; 74
ref_1
Biswas (ref_3) 2019; 3
ref_2
Turnbaugh (ref_41) 2009; 457
Hadi (ref_9) 2020; 60
Eckburg (ref_49) 2005; 308
ref_48
Wick (ref_22) 2019; 20
Pengrattanachot (ref_32) 2022; 13
Jitvaropas (ref_21) 2022; 247
References_xml – volume: 457
  start-page: 480
  year: 2009
  ident: ref_41
  article-title: A core gut microbiome in obese and lean twins
  publication-title: Nature
  doi: 10.1038/nature07540
– volume: 47
  start-page: 102216
  year: 2019
  ident: ref_33
  article-title: Clinical and psychological responses to synbiotic supplementation in obese or overweight adults: A randomized clinical trial
  publication-title: Complement. Ther. Med.
  doi: 10.1016/j.ctim.2019.102216
– volume: 50
  start-page: 952
  year: 2004
  ident: ref_18
  article-title: Trolox-equivalent antioxidant capacity assay versus oxygen radical absorbance capacity assay in plasma
  publication-title: Clin. Chem.
  doi: 10.1373/clinchem.2004.031526
– volume: 203
  start-page: 105737
  year: 2020
  ident: ref_36
  article-title: Abdominal obesity, adipokines and non-communicable diseases
  publication-title: J. Steroid. Biochem. Mol. Biol.
  doi: 10.1016/j.jsbmb.2020.105737
– volume: 49
  start-page: 155
  year: 2014
  ident: ref_63
  article-title: Synbiotic food consumption reduces levels of triacylglycerols and VLDL, but not cholesterol, LDL, or HDL in plasma from pregnant women
  publication-title: Lipids
  doi: 10.1007/s11745-013-3867-2
– volume: 47
  start-page: 789
  year: 1988
  ident: ref_16
  article-title: Electrical impedance in assessing human body composition: The BIA method
  publication-title: Am. J. Clin. Nutr.
  doi: 10.1093/ajcn/47.5.789
– volume: 36
  start-page: 1197
  year: 2017
  ident: ref_12
  article-title: Effects of inulin-type fructans, galacto-oligosaccharides and related synbiotics on inflammatory markers in adult patients with overweight or obesity: A systematic review
  publication-title: Clin. Nutr.
  doi: 10.1016/j.clnu.2016.10.003
– volume: 25
  start-page: 30
  year: 2017
  ident: ref_15
  article-title: The additional effects of a probiotic mix on abdominal adiposity and antioxidant Status: A double-blind, randomized trial
  publication-title: Obesity
  doi: 10.1002/oby.21671
– volume: 308
  start-page: 1635
  year: 2005
  ident: ref_49
  article-title: Diversity of the human intestinal microbial flora
  publication-title: Science
  doi: 10.1126/science.1110591
– volume: 71
  start-page: 8228
  year: 2005
  ident: ref_47
  article-title: UniFrac: A new phylogenetic method for comparing microbial communities
  publication-title: Appl. Environ. Microbiol.
  doi: 10.1128/AEM.71.12.8228-8235.2005
– volume: 21
  start-page: 454
  year: 2018
  ident: ref_39
  article-title: Lactobacillus gasseri BNR17 supplementation reduces the visceral fat accumulation and waist circumference in obese adults: A randomized, double-blind, placebo-controlled trial
  publication-title: J. Med. Food
  doi: 10.1089/jmf.2017.3937
– volume: 51
  start-page: 167
  year: 2016
  ident: ref_28
  article-title: The gut microbiome and its role in obesity
  publication-title: Nutr. Today
  doi: 10.1097/NT.0000000000000167
– volume: 15
  start-page: 799
  year: 2020
  ident: ref_26
  article-title: Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data
  publication-title: Nat. Protoc.
  doi: 10.1038/s41596-019-0264-1
– volume: 34
  start-page: 413
  year: 2005
  ident: ref_30
  article-title: Bioecologic control of the gastrointestinal tract: The role of flora and supplemented probiotics and synbiotics
  publication-title: Gastroenterol. Clin. N. Am.
  doi: 10.1016/j.gtc.2005.05.002
– ident: ref_48
  doi: 10.3390/nu12010222
– volume: 9
  start-page: 1087
  year: 2015
  ident: ref_42
  article-title: Obesity and the microbiome
  publication-title: Expert Rev. Gastroenterol. Hepatol.
  doi: 10.1586/17474124.2015.1051029
– volume: 139
  start-page: 141
  year: 2019
  ident: ref_58
  article-title: The effect of vitamin D supplementation on oxidative stress parameters: A systematic review and meta-analysis of clinical trials
  publication-title: Pharmacol. Res.
  doi: 10.1016/j.phrs.2018.11.011
– volume: 3
  start-page: nzz026
  year: 2019
  ident: ref_3
  article-title: Current progress and future directions in the double burden of malnutrition among women in South and Southeast Asian countries
  publication-title: CND
– volume: 42
  start-page: 315
  year: 2014
  ident: ref_17
  article-title: Consumption of Mesona chinensis attenuates postprandial glucose and improves antioxidant status induced by a high carbohydrate meal in overweight subjects
  publication-title: Am. J. Chin. Med.
  doi: 10.1142/S0192415X14500219
– volume: 37
  start-page: 1600
  year: 2021
  ident: ref_24
  article-title: NanoCLUST: A species-level analysis of 16S rRNA nanopore sequencing data
  publication-title: J. Bioinform.
  doi: 10.1093/bioinformatics/btaa900
– volume: 60
  start-page: 584
  year: 2020
  ident: ref_9
  article-title: Efficacy of synbiotic supplementation in obesity treatment: A systematic review and meta-analysis of clinical trials
  publication-title: Crit. Rev. Food Sci. Nutr.
  doi: 10.1080/10408398.2018.1545218
– volume: 2
  start-page: 799
  year: 2012
  ident: ref_4
  article-title: Obesity-induced endoplasmic reticulum stress causes chronic inflammation in adipose tissue
  publication-title: Sci. Rep.
  doi: 10.1038/srep00799
– volume: 30
  start-page: 81
  year: 2019
  ident: ref_62
  article-title: Effects of probiotics and synbiotic supplementation on antioxidant status: A meta-analysis of randomized clinical trials
  publication-title: Clin. Nutr. ESPEN
  doi: 10.1016/j.clnesp.2019.02.003
– ident: ref_14
  doi: 10.3390/nu13020666
– volume: 22
  start-page: 7588
  year: 2018
  ident: ref_65
  article-title: Probiotics, prebiotics and synbiotics for weight loss and metabolic syndrome in the microbiome era
  publication-title: Eur. Rev. Med. Pharmacol. Sci.
– volume: 10
  start-page: 121
  year: 2019
  ident: ref_13
  article-title: Probiotic or synbiotic alters the gut microbiota and metabolism in a randomised controlled trial of weight management in overweight adults
  publication-title: Benef. Microbes
  doi: 10.3920/BM2018.0028
– volume: 96
  start-page: 219
  year: 2004
  ident: ref_31
  article-title: Monostrain, multistrain and multispecies probiotics—A comparison of functionality and efficacy
  publication-title: Int. J. Food Microbiol.
  doi: 10.1016/j.ijfoodmicro.2004.05.012
– volume: 10
  start-page: 855
  year: 2019
  ident: ref_34
  article-title: Effect of multi-strain probiotic (UB0316) in weight management in overweight/obese adults: A 12-week double blind, randomised, placebo-controlled study
  publication-title: Benef. Microbes
  doi: 10.3920/BM2019.0052
– volume: 74
  start-page: 1251
  year: 2020
  ident: ref_51
  article-title: Profile of the gut microbiota of adults with obesity: A systematic review
  publication-title: Eur. J. Clin. Nutr.
  doi: 10.1038/s41430-020-0607-6
– ident: ref_61
  doi: 10.3390/foods10071580
– volume: 247
  start-page: 1937
  year: 2022
  ident: ref_21
  article-title: Classification of salivary bacteriome in asymptomatic COVID-19 cases based on long-read nanopore sequencing
  publication-title: Exp. Biol. Med.
  doi: 10.1177/15353702221118091
– volume: 8
  start-page: e9230
  year: 2020
  ident: ref_6
  article-title: Plasma antioxidants and oxidative stress status in obese women: Correlation with cardiopulmonary response
  publication-title: PeerJ
  doi: 10.7717/peerj.9230
– volume: 13
  start-page: 5925
  year: 2022
  ident: ref_32
  article-title: The impact of prebiotic fructooligosaccharides on gut dysbiosis and inflammation in obesity and diabetes related kidney disease
  publication-title: Food Funct.
  doi: 10.1039/D1FO04428A
– volume: 24
  start-page: 2301
  year: 2016
  ident: ref_56
  article-title: Reactive oxygen species and oxidative stress in obesity—Recent findings and empirical approaches
  publication-title: Obesity
  doi: 10.1002/oby.21654
– volume: 20
  start-page: 129
  year: 2019
  ident: ref_22
  article-title: Performance of neural network basecalling tools for Oxford Nanopore sequencing
  publication-title: Genome. Biol.
  doi: 10.1186/s13059-019-1727-y
– volume: 26
  start-page: 40
  year: 2021
  ident: ref_27
  article-title: Comparison of nutrient intake in Lao PDR by the Korean CAN-pro and Thailand INMUCAL analysis programs
  publication-title: Prev. Nutr. Food Sci.
  doi: 10.3746/pnf.2021.26.1.40
– volume: 123
  start-page: 1127
  year: 2020
  ident: ref_29
  article-title: Microbial dysbiosis-induced obesity: Role of gut microbiota in homoeostasis of energy metabolism
  publication-title: Br. J. Nutr.
  doi: 10.1017/S0007114520000380
– volume: 11
  start-page: 1248
  year: 2019
  ident: ref_60
  article-title: The effects of synbiotic supplementation on metabolic status in diabetic patients undergoing hemodialysis: A randomized, double-blinded, placebo-controlled trial
  publication-title: Probiotics Antimicrob. Proteins
  doi: 10.1007/s12602-018-9499-3
– ident: ref_2
  doi: 10.1186/s13104-020-05408-4
– volume: 31
  start-page: 442
  year: 2003
  ident: ref_25
  article-title: The Ribosomal Database Project (RDP-II): Previewing a new autoaligner that allows regular updates and the new prokaryotic taxonomy
  publication-title: Nucleic. Acids Res.
  doi: 10.1093/nar/gkg039
– volume: 6
  start-page: 775
  year: 2015
  ident: ref_35
  article-title: Effects of synbiotic on anthropometry, lipid profile and oxidative stress in obese children
  publication-title: Benef. Microbes
  doi: 10.3920/BM2015.0011
– volume: 12
  start-page: 17291
  year: 2022
  ident: ref_53
  article-title: Brief overview of dietary intake, some types of gut microbiota, metabolic markers and research opportunities in sample of Egyptian women
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-022-21056-z
– volume: 59
  start-page: 3049
  year: 2010
  ident: ref_8
  article-title: Differential adaptation of human gut microbiota to bariatric surgery–induced weight loss: Links with metabolic and low-grade inflammation markers
  publication-title: Diabetes
  doi: 10.2337/db10-0253
– volume: 444
  start-page: 1027
  year: 2006
  ident: ref_44
  article-title: An obesity-associated gut microbiome with increased capacity for energy harvest
  publication-title: Nature
  doi: 10.1038/nature05414
– ident: ref_50
  doi: 10.3390/microorganisms8111715
– volume: 5
  start-page: 18
  year: 2019
  ident: ref_46
  article-title: Gut microbiota phenotypes of obesity
  publication-title: NPJ Biofilms Microbiomes
  doi: 10.1038/s41522-019-0091-8
– volume: 24
  start-page: 148
  year: 2020
  ident: ref_52
  article-title: The first report of differences in gut microbiota composition between obese and normal weight Iranian subjects
  publication-title: Iran. Biomed. J.
  doi: 10.29252/ibj.24.3.148
– volume: 13
  start-page: 423
  year: 2015
  ident: ref_57
  article-title: Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: Causes and therapeutic strategies
  publication-title: Metab. Syndr. Relat. Disord.
  doi: 10.1089/met.2015.0095
– volume: 9
  start-page: 1123
  year: 2021
  ident: ref_55
  article-title: Linking gut microbiota, metabolic syndrome and metabolic health among a sample of obese Egyptian females
  publication-title: Open. Access. Maced. J. Med. Sci.
  doi: 10.3889/oamjms.2021.7625
– ident: ref_23
  doi: 10.3390/nu11112690
– volume: 12
  start-page: 3117
  year: 2011
  ident: ref_59
  article-title: Inflammation, oxidative stress, and obesity
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms12053117
– volume: 19
  start-page: 679
  year: 2018
  ident: ref_43
  article-title: Measuring the diversity of the human microbiota with targeted next-generation sequencing
  publication-title: Brief. Bioinform.
– ident: ref_1
  doi: 10.1186/s12889-021-10403-w
– volume: 41
  start-page: 60
  year: 2021
  ident: ref_10
  article-title: Metabolic syndrome and synbiotic targeting of the gut microbiome
  publication-title: Curr. Opin. Food Sci.
  doi: 10.1016/j.cofs.2021.02.014
– volume: 42
  start-page: 424
  year: 2018
  ident: ref_45
  article-title: Body size phenotypes comprehensively assess cardiometabolic risk and refine the association between obesity and gut microbiota
  publication-title: Int. J. Obes.
  doi: 10.1038/ijo.2017.281
– volume: 207
  start-page: 604
  year: 1999
  ident: ref_20
  article-title: Improving the thiobarbituric acid-reactive-substances assay for estimating lipid peroxidation in plant tissues containing anthocyanin and other interfering compounds
  publication-title: Planta
  doi: 10.1007/s004250050524
– volume: 23
  start-page: 581
  year: 2015
  ident: ref_54
  article-title: Toll-like receptor 5 in obesity: The role of gut microbiota and adipose tissue inflammation
  publication-title: Obesity
  doi: 10.1002/oby.20993
– volume: 82
  start-page: 70
  year: 1959
  ident: ref_19
  article-title: Tissue sulfhydryl groups
  publication-title: Arch. Biochem. Biophys.
  doi: 10.1016/0003-9861(59)90090-6
– volume: 102
  start-page: 11070
  year: 2005
  ident: ref_7
  article-title: Obesity alters gut microbial ecology
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0504978102
– volume: 37
  start-page: 67
  year: 2018
  ident: ref_38
  article-title: Effects of Bifidobacterium breve B-3 on body fat reductions in pre-obese adults: A randomized, double-blind, placebo-controlled trial
  publication-title: Biosci. Microbiota Food Health
  doi: 10.12938/bmfh.18-001
– ident: ref_64
  doi: 10.3390/ijerph17207618
– volume: 1
  start-page: 22
  year: 2012
  ident: ref_40
  article-title: Impact of the gut microbiota on the development of obesity: Current concepts
  publication-title: Am. J. Gastroenterol. Suppl.
  doi: 10.1038/ajgsup.2012.5
– volume: 16
  start-page: 294
  year: 2019
  ident: ref_11
  article-title: The effects of synbiotic supplementation on body mass index, metabolic and inflammatory biomarkers, and appetite in patients with metabolic syndrome: A triple-blind randomized controlled trial
  publication-title: J. Diet. Suppl.
  doi: 10.1080/19390211.2018.1455788
– volume: 29
  start-page: 213
  year: 2015
  ident: ref_37
  article-title: The effects of symbiotic therapy on anthropometric measures, body composition and blood pressure in patient with metabolic syndrome: A triple blind RCT
  publication-title: Med. J. Islam. Repub. Iran.
– volume: 38
  start-page: 1
  year: 2019
  ident: ref_5
  article-title: Association of antioxidant status and inflammatory markers with metabolic syndrome in Thais
  publication-title: J. Health Popul. Nutr.
  doi: 10.1186/s41043-018-0158-9
SSID ssj0000070763
Score 2.4447896
Snippet Studies investigating the effect of multispecies synbiotic supplementation in obesity management are limited. The current study was performed to evaluate the...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1863
SubjectTerms antioxidant activity
Antioxidants
Antioxidants - pharmacology
Bacteroidetes
blood
Body Composition
Body fat
Body mass index
Cytokines
Diet therapy
Dietary supplements
digestive system
Double-Blind Method
Double-blind studies
Firmicutes
fructooligosaccharides
Gastrointestinal Microbiome
Gastrointestinal system
Health aspects
Humans
Inflammation
intestinal microorganisms
malondialdehyde
maltodextrins
Metabolism
microbiome
Microbiota
Microbiota (Symbiotic organisms)
Obesity
Obesity - therapy
Overweight
Overweight - therapy
Oxidative stress
Physiological aspects
placebos
Plasma
Prebiotics
Probiotics
Synbiotics
Tumor necrosis factor-TNF
waist circumference
Weight control
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLZgvPCCgHEJDHQQCITUaHOcxAkvKJsYE9IAAZP6FsWxIyK1zqCNRPmB_C7OsdNsQYDUl9YnTlLb5-bP32HsWaayhjhQQqUyHaI9jsNcRSKM8yxJlJQy1ZSHPH2fnpzF7-bJfEi4rQZY5VYnOkWtu5py5Pt-B5DHMn59_i2kqlG0uzqU0LjKrhF1GUG65FyOORbHZZMKz0oqMLrftz3xn_MsFRM79Kc2vmSOplDJS7bn-Ca7MTiNUPhRvsWuGHub7RYWA-blBp6Dg3G6_Pgu--X5iKFroAJ3vJYOU2I8DJ83VrUddgGulKeHjdO4AH4OO70BUg4DiGsGBeEgf7Qa_3ogl7RfzaCyGt72azhtPX_TErttLXxw6GoK850EFRsweBNFOZ7VKyjgE_7cLdufRs8AXXa1MOEh-rf47SOl8VUXHnnI_MJoIGjj5g47O37z5egkHIo1hHUixTrM41RHjTSNkQ0V_WwSUVVCCOKPqWXVZCJTSovUpEZhjMWrWvOsQQuKN9HoNIm7bMd21txnwE2sc0LP8aqK48agmEFFo2qKFQWvAvZyO3RlPTCZU0GNRYkRDQ1zeTHMAXs6yp57_o6_Sr2gGVDSosae6mo4m4DPQ_RYZYFBV0x71nnA9iaSuBjrafN2DpWDMliVF1M3YE_GZrqSAG7WdL2TkXl0gLHOv2UEKlxHhpQF7J6fluM7CcnpQAdenU0m7ChANOLTFtt-dXTi3GN9owf_f_aH7HqEDh7tpHGxx3bW33vzCB2ytXrsVt1v63c5Kg
  priority: 102
  providerName: ProQuest
Title Effect of a Multispecies Synbiotic Supplementation on Body Composition, Antioxidant Status, and Gut Microbiomes in Overweight and Obese Subjects: A Randomized, Double-Blind, Placebo-Controlled Study
URI https://www.ncbi.nlm.nih.gov/pubmed/37111082
https://www.proquest.com/docview/2806591474
https://www.proquest.com/docview/2807920772
https://www.proquest.com/docview/3040404318
https://pubmed.ncbi.nlm.nih.gov/PMC10141052
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ti9NAEF7u5YtfRD1fomcZURSh8dxskk0EkfS4F4Sex2mh30I2u8FAm-i1hYs_0N_lTDatl-MEoV_SnU3azOzOzO6zzzD2KlJRQRworlKRdtEf-26sPOH6cRQESkoZalqHHJ-FpxP_8zSYbrF1_c7uBS5uTe2ontTkcvbu6mfzCQf8R8o4MWU_qFZEas6jUGyzXfRIkgbouAvzbRgsMV2nzWbvvfTcEL2wZSq90b3nm27O0NdcVB8-ec0fHd9jd7tAEhKr-ftsy1QP2F5SYRI9b-A1tNDOds18j_22HMVQF5BBe-SWDlhijgxfm0qVNd4C2vKeFkpOugL8jGrdAE0YHbBrCAlhI69KjeoAClNXiyFklYaT1RLGpeV0muNtywq-tIhrSv1bCSpAYPAhitZ9Fh8ggQv8up6Xv4weAobxambcEca8eHVOS_uqdg8tjH5mNBDcsXnIJsdH3w5P3a6Ag5sHUizd2A-1V0hTGFlQIdAiEFkmhCBOmVxmRSQipbQITWgU5l08yzWPCvSq-BCNgZR4xHaqujJPGHDj65gQdTzLfL8wKGZw8lE55Y-CZw57u1Zdmnfs5lRkY5ZilkNqTv-q2WEvN7I_LKfHrVJvyAJSMj28U5515xXw9xBlVppgIubTPnbssP2eJA7QvN-8tqF0bd-p3dDmKOOwF5tm6kmgt8rUq1ZGxmix0vu3jMBJuCVIihz22Jrl5j8JyemQB_aOega7ESBq8X5LVX5vKca5xf96T__7JTxjdzyM_2ijjYt9trO8XJnnGK8t1YBty6kcsN3R0dn5BV6dTPmgHaB_AFoARHY
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEF2V9AFeEFAugQKDuAkpVmuvr0gIOaUlpU2oepH6ZrzetbCU2IUkgvBRfAbfxcyu49YIeKuUF2fHa1szO7sze_YMY89CEebEgWIJEUoL52PXioTDLTcKPU8EQeBLykMOR_7gxP1w6p2usJ_LszAEq1z6RO2oZZVRjnzD7ADabuC-PftiUdUo2l1dltAwZrGnFt8wZJu-2X2H-n3uODvbx1sDq64qYGVewGdUU146eaByFeRUnTL3eJpyDOs97mVBmoc8FEJyX_lKYDBgp5m0wxxdfaaEpOL02O8VtupyDGU6bLW_PTo4bLI6mj3H54YHlfNoc6OcE-O6Hfq8NfP96f8vTIBtcOaF2W7nBrteL1MhNnZ1k62o8hZbi0sM0ScLeAEaOKoz8mvsl2FAhiqHFPSBXjq-iRE4HC1KUVTYBejioQaoTpYA-OtXcgHkjmrYWA9iQl5-LyQqG2gRPJ_2IC0lvJ_PYFgYxqgJdluU8FHjuSmxoCWovIHChwjKKk1fQwyH-Hc1KX4o2QMMEsRYWX1cUePVAW0ciMraMiD9sZJAYMrFbXZyKYq8wzplVap7DGzlyojwenaaum6uUEyhaxMZRafcTrvs1VJ1SVZzp1MJj3GCMRSpOTlXc5c9bWTPDGPIX6VekgUk5EawpyytT0Pg-xAhVxJjmOfSLnnUZestSRz-Wbt5aUNJ7X6myflg6bInTTPdSZC6UlVzLRNEziZGV_-W4ejiNf1S2GV3jVk238QDm46Q4N1hy2AbASIub7eUxWdNYG4bdLFz___v_phdHRwP95P93dHeA3bNweUl7ePZfJ11Zl_n6iEuB2fiUT0GgX267GH_G9mpeCs
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1tb9MwELbGkBBfEDBeCgMO8SakRp3jJE6QEOo2ysbYmAaT-i3EsSMitcmgraD8NH4Av4s7O-0WBHyb1C-pL06iO59958fPMfY4VnFBHCieUrH2cD4OvET5wguSOAyVlDLSlIfcP4h2joO3w3C4wn4uzsIQrHLhE62j1nVOOfKe2wHkgQx6RQOLONwevDr54lEFKdppXZTTcCayZ-bfMHybvNzdRl0_8f3B649bO15TYcDLQymmVF9e-4U0hZEFVaosQpFlAkP8UIS5zIpYxEppEZnIKAwMeJZrHhfo9nOjNBWqx34vsItShJzGmBzKZX7H8uhEwjGiCpFs9KoZca_zOBKtOfDPmeDMVNiGaZ6Z9wZX2ZVmwQp9Z2HX2IqprrO1foXB-ngOT8FCSG1ufo39clzIUBeQgT3aSwc5MRaHD_NKlTV2AbaMqIOsk00A_jZrPQdyTA2ArAt9wmB-LzWqHWg5PJt0Ias0vJlNYb903FFj7Las4L1FdlOKwUpQoQODD1GUX5q8gD4c4d_1uPxhdBcwXFAj423i2hqvDmkLQdXeloPrj4wGglXOb7Djc1HjTbZa1ZW5zYCbQCeE3ONZFgSFQTGDTk7lFKcKnnXY84Xq0rxhUadiHqMUoylSc3qq5g57tJQ9cdwhf5V6RhaQkkPBnvKsOReB70PUXGkfA76A9suTDltvSaIjyNvNCxtKG0c0SU-HTYc9XDbTnQSuq0w9szIy8Tcwzvq3jEBnb4mY4g675cxy-U1CcjpMgnfHLYNdChCFebulKj9bKnPucMb-nf-_-wN2CQd7-m73YO8uu-zjOpM29LhYZ6vTrzNzD9eFU3XfDkBgn857xP8G05d6-w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+a+Multispecies+Synbiotic+Supplementation+on+Body+Composition%2C+Antioxidant+Status%2C+and+Gut+Microbiomes+in+Overweight+and+Obese+Subjects%3A+A+Randomized%2C+Double-Blind%2C+Placebo-Controlled+Study&rft.jtitle=Nutrients&rft.au=Oraphruek%2C+Piyarat&rft.au=Chusak%2C+Charoonsri&rft.au=Ngamukote%2C+Sathaporn&rft.au=Sawaswong%2C+Vorthon&rft.date=2023-04-13&rft.pub=MDPI+AG&rft.issn=2072-6643&rft.eissn=2072-6643&rft.volume=15&rft.issue=8&rft_id=info:doi/10.3390%2Fnu15081863&rft.externalDocID=A747467279
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2072-6643&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2072-6643&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2072-6643&client=summon